Chronically Active Lesions as a Trial Outcome in Multiple Sclerosis: A New Perspective on an Old Foe. Chard DT. Neurology 2024;102:e209246.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chard DT. Chronically Active Lesions as a Trial Outcome in Multiple Sclerosis: A New Perspective on an Old Foe. Neurology 2024;102:e209246.
PMID: 38335501